CompaniesByCap
COR
Cencora, Inc. (COR)
NYSE · Healthcare

Cencora, Inc. Revenue 2007–2025

Cencora, Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Cencora, Inc. revenue for the quarter ending March 31, 2026 was 78.4 B, a 3.85% increase year-over-year.
  • Cencora, Inc. revenue for the twelve months ending March 31, 2026 was 320.4 B, a 8.10% increase year-over-year.
  • Cencora, Inc. annual revenue for 2025 was 321.3 B, a 9.31% increase from 2024.
  • Cencora, Inc. annual revenue for 2024 was 294.0 B, a 12.12% increase from 2023.
  • Cencora, Inc. annual revenue for 2023 was 262.2 B, a 9.89% increase from 2022.
  • Cencora, Inc. annual revenue for 2022 was 238.6 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Cencora, Inc. (COR) — Frequently Asked Questions

Cencora, Inc. (COR) is a publicly traded US company. It has a market capitalization of $55.28B. In fiscal 2025 it reported revenue of $321.33B and net income of $1.55B. Explore COR's stock price, financial statements, earnings history, margins and key ratios below.

What is Cencora, Inc.'s market cap?

Cencora, Inc. (COR) has a market capitalization of $55.28B.

What is the COR stock price?

COR trades at $283.19 (+0.69% on the day).

How much revenue does Cencora, Inc. make?

Cencora, Inc. reported revenue of $321.33B in fiscal 2025.

Is COR profitable?

In fiscal 2025, Cencora, Inc. reported net income of $1.55B.